Form 4 for PLAB PHOTRONICS INC
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-14 · accession 0001567619-22-001263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-18 | 2022-01-14 | PLAB | KIRLIN PETER S | CEO | M - OptEx | $11.35 | +4,821 | 454.7K | +1% | +$54.7K |
| DM | 2022-01-18 | 2022-01-14 | PLAB | KIRLIN PETER S | CEO | S - Sale+OE | $19.58 | -4,821 | 451.2K | -1% | -$94.4K |
| DM | 2022-01-18 | 2022-01-14 | PLAB | KIRLIN PETER S | CEO | M - OptEx | $0.00 | -4,821 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-14 | M | A | 1,323 | $11.35 | 452,562 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-14 | S | D | 3,498 | $19.57 | 451,239 | D | — | — | (F2) Net proceeds of sale to offset a tax liability from restricted stock vesting and to fund children's education. (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-01-14 | M | A | 3,498 | $11.35 | 454,737 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-14 | S | D | 1,323 | $19.59 | 451,239 | D | — | — | (F2) Net proceeds of sale to offset a tax liability from restricted stock vesting and to fund children's education. (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 5 | Derivative | Stock Options (Right to Buy) | 2022-01-14 | M | D | 1,323 | $0.00 | 0 | D | $11.35 · 2021-01-03 to 2027-01-03 | 1,323 Common Stock | |
| 6 | Derivative | Non-Qualified Stock Options | 2022-01-14 | M | D | 3,498 | $0.00 | 0 | D | $11.35 · 2021-01-03 to 2027-01-03 | 3,498 Common Stock |